Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$618,531
+$82,201 QoQ
Shares Held
2,458
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#2,979
of 4,152 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EPG Wealth Management LLC holds $13,175,595 across 8 Drug Manufacturers - General names. ABBV ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,768 | $5,718,882 | |
| 2 | AMGN |
Amgen Inc
|
7,115 | $2,576,483 | |
| 3 | JNJ |
Johnson & Johnson
|
7,745 | $1,966,997 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
14,133 | $814,343 | |
| 5 | AZN |
Astrazeneca PLC
|
4,026 | $763,410 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
2,458 | $618,531 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,023 | $508,265 | |
| 8 | MRK |
Merck & Co., Inc.
|
1,624 | $208,684 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $618,531 | 2,458 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $536,330 | 2,466 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $586,305 | 2,566 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $551,991 | 2,384 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $442,889 | 2,386 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,010,933 | 4,825 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $853,314 | 4,802 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,183,892 | 5,995 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $0 | 0 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,315,672 | 7,225 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,124,617 | 7,257 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,092,609 | 7,330 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $961,029 | 7,133 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,158,938 | 7,272 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,526,244 | 9,444 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,243,724 | 9,267 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $1,331,726 | 8,695 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,392,200 | 8,588 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,081,981 | 7,991 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $800,179 | 7,418 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $721,797 | 6,408 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $443,702 | 4,100 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $435,457 | 4,064 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $353,425 | 4,035 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $384,767 | 3,919 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $252,493 | 3,314 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||